EUVIMEDEUVIMED entdecken
Crossref

L26/O-095 Age limits for safe pregnancy in oocyte donation: evaluating the increased incidence of maternal and neonatal complications beyond natural reproductive limits

M. Volotovskaya, M.E. Coccia, P. Evangelisti, D. De Angelis, F. Rizzello, L. Badolato, F. Piazzini, R. Fucci, P. Falcone, I. Asia, A. Morucchio

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M. Volotovskaya und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question The objective of this 10-year prospective study is to assess the safety and obstetric/neonatal outcomes of oocyte donation (OD) in relation to maternal age. Summary answer The use of OD has increased significantly over the last few decades, becoming an integral part reproductive treatments for women, particularly in advanced maternal age. What is known already According to the National IVF Registry (ISS), OD currently accounts for 10% of all assisted reproductive technology procedures in Italy, with a reported average maternal age of 41.9 years in 2022. While maternal age is a non-modifiable risk factor for obstetric and neonatal complications, a multidisciplinary approach—incorporating intensive monitoring and personalized treatment protocols—has significantly improved outcomes. However, these risks have not been entirely eliminated. Study design, size, duration Prospective study analyzing pregnancy outcomes following OD from May 2015 to August 2024. In patients under 45 years, embryo transfers consisted of either one blastocyst or two cleavage-stage embryos. A total of 550 singleton pregnancies and newborns were analyzed. Participants/materials, setting, methods Inclusion criteria targeted singleton pregnancies achieved through Level II/III OD procedures. Obstetric and perinatal outcomes were evaluated and stratified by maternal age: ≤ 44 (n = 372), 45–46 (n = 98), 47–49 (n = 67), and ≥ 50 years (n = 13). Main results and the role of chance The OD age group ≤44 age group showed the most favorable obstetric and perinatal outcomes. Patients aged 45–46 experienced significantly higher complication rates compared to the ≤44 group, including: Gestational Diabetes (GDM) (28.6% vs 11.0%, p < 0.05), preeclampsia (18.4% vs 3.8%, p < 0.05), cholestasis gravidarum (6.1% vs 3.0%, p < 0.05), and post-partum hemorrhage (PPH) requiring transfusion (7.1% vs 1.9%, p < 0.05). Cesarean section rates were significantly higher (86.7% vs 58.1%, p < 0.05) and preterm birth more frequent (27.6% vs 8.3%, p < 0.05) in the older group. Vaginal delivery was significantly less frequent in the 45–46 group (13.3% vs. 50.8%). Complications increased markedly with advancing age: in the 47–49 group, GDM reached 35.8% (n = 24) and preeclampsia 23.6% (n = 16). In the ≥50 group, GDM and PPH both affected 38.5% of patients, and 46% of neonates were born preterm. Cesarean section rates reached 91.0% (n = 61) in women aged 47–49 and 100% (n = 13) in those ≥50. Limitations, reasons for caution not applicable Wider implications of the findings OD pregnancies ≥45 years are associated with significantly higher rate of obstetric and neonatal complications (GDM, preeclampsia, PPH, preterm birth), compromising maternal and neonatal safety. These pregnancies require mandatory management in high-risk pregnancy units to ensure specialized surveillance and mitigate life-threatening complications for both mother and child. Trial registration number No

Zitieren

APA

Volotovskaya, M., Coccia, M., Evangelisti, P., Angelis, D. D., Rizzello, F., Badolato, L., Piazzini, F., Fucci, R., Falcone, P., Asia, I., & Morucchio, A. (2026). L26/O-095 Age limits for safe pregnancy in oocyte donation: evaluating the increased incidence of maternal and neonatal complications beyond natural reproductive limits. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.095

Vancouver

Volotovskaya M, Coccia M, Evangelisti P, Angelis DD, Rizzello F, Badolato L, et al. L26/O-095 Age limits for safe pregnancy in oocyte donation: evaluating the increased incidence of maternal and neonatal complications beyond natural reproductive limits. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.095

BibTeX
@article{Volotovskaya2026,
  author = {Volotovskaya, M. and Coccia, M.E. and Evangelisti, P. and Angelis, D. De and Rizzello, F. and Badolato, L. and Piazzini, F. and Fucci, R. and Falcone, P. and Asia, I. and Morucchio, A.},
  title = {L26/O-095 Age limits for safe pregnancy in oocyte donation: evaluating the increased incidence of maternal and neonatal complications beyond natural reproductive limits},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.095}
}
Kostenlos starten →